Professor Kwabena Frimpong-Manso Opuni and Dr Delese Mimi Darko,
Professor Kwabena Frimpong-Manso Opuni and Dr Delese Mimi Darko,
The Food and Drugs Authority (FDA) has announced the appointment of Professor Kwabena Frimpong-Manso Opuni as its new Acting Chief Executive Officer (CEO), effective Monday, July 14, 2025.
Prof. Opuni steps into the role following the departure of Dr Delese Mimi Darko, who served as CEO of the Authority for eight years and was recently appointed Director General of the Africa Medicines Agency (AMA). Dr. Darko’s tenure at the FDA was widely recognized for its regulatory reforms and public health impact, earning both local and international commendation.
Before his new appointment, Prof. Opuni served as the Board Chairman of the FDA, bringing with him a strong background in leadership and policy oversight. His elevation to the role of Acting CEO signals a commitment to continuity and institutional strength within the FDA.
In a statement, the Authority expressed confidence in Prof. Opuni’s ability to lead its efforts in protecting public health and ensuring the safety, efficacy, and quality of medical products, foods, cosmetics, and household substances on the Ghanaian market.
“The FDA extends its warmest congratulations to Professor Opuni on his appointment and looks forward to his leadership in advancing the Authority’s mandate of safeguarding public health and safety,” the statement read.
Prof. Opuni is expected to steer the Authority through a period of rapid development, as it strengthens regulatory systems, deepens regional cooperation, and addresses emerging challenges in health and consumer protection.
